Identification of chronic myeloid leukemia patients treated with imatinib who are potentially eligible for treatment discontinuation by assessing real-life molecular responses on the international scale in a EUTOS-certified lab
Source: Leukemia Research - Category: Hematology Authors: Am élie Heinrichs, Barbara Dessars, Hakim El Housni, Wim Pluymers, Karen Peeters, Fleur S. Benghiat, Pierre Heimann Tags: Research paper Source Type: research